Precision cancer therapies for gynecologic cancers at The Women's Cancer Center

In the United States, a woman receives a gynecologic cancer diagnosis of cervical, ovarian, endometrial/uterine or vaginal cancer every 5 minutes. In fact, more than 110,000 women will be diagnosed with a gynecologic cancer this year and approximately 32,000 women will die from these cancers.

The Women's Cancer Center at The University of Kansas Cancer Center focuses exclusively on gynecologic and breast cancers, providing the gold standard of cancer care to women.

Here, specialists from one of the country's leading National Cancer Institute-designated cancer centers offer world-class cancer care, including more options and expertise to treat gynecologic cancers. no one else in the region comes close. The first step in caring for you begins the moment you call. Appointments are available within 24 hours.

Our gynecologic oncologists are experts in screening, early detection and treatment of gynecologic cancers. They provide the most innovative technologies and techniques available in the Kansas City region. Because a patient's tumor molecular data is integral to all treatment decisions, our specialists design effective personalized treatment plans for each patient based on their genetic, environmental and lifestyle factors. Patients also receive expert guidance from an experienced gynecologic cancer nurse navigator. Our gynecologic cancer nurse navigator assists patients every step of the way, beginning with physician selection.

Our fellowship-trained gynecologic oncologists are nationally recognized disease-dedicated specialists. They provide the most advanced medical and surgical care for gynecologic cancer patients, and access to nationally recognized leading-edge treatment through clinical trials. Our renowned physicians/investigators conduct pivotal research that propels gynecologic cancer care forward, leading to improved treatments and innovative patient care. We also provide a prevention program for patients at high risk for developing gynecologic cancers that focuses on screening and risk reduction.